Effects of Orange Oil Aromatherapy on Pain and Anxiety During Invasive Interventions in Patients With Hematopoietic Stem Cell Transplants.
Seckin ErdalMerve Harman ÖzdoğanDilek YildirimAyşem KuniSevinc SelçukAzize GüneriElif Naz ArslanPublished in: Journal of infusion nursing : the official publication of the Infusion Nurses Society (2024)
Invasive interventions, such as peripheral intravenous cannula, port needle placement, and blood collection, are often required for both inpatient and outpatient follow-up patients with hematological malignancies and hematopoietic stem cell transplants. This prospective, randomized controlled experimental study assessed the effect of orange oil inhalation used in aromatherapy on pain and anxiety levels in invasive interventions with hematological malignancies and hematopoietic stem cell transplants. It was conducted prospectively with 80 patients with hematological malignancies who were treated in the adult bone marrow transplant unit and adult hematology service of a private hospital between May 2021 and April 2022. The orange oil inhalation used in aromatherapy was applied to patients in the intervention group. The Visual Analog Scale (VAS) and State-Trait Anxiety Inventory (STAI) were used for data collection. Regarding the personal characteristics of the patients, 42.5% were ≥61 years old, 60% were men, and 85% were married. VAS pain scores of the intervention group were statistically lower than those of the control group (P < .001). However, there was no statistically significant difference in the STAI scores of groups (P >.05). The study results show that orange oil inhalation has been determined to reduce pain during invasive interventions.
Keyphrases
- hematopoietic stem cell
- chronic pain
- end stage renal disease
- pain management
- chronic kidney disease
- physical activity
- neuropathic pain
- healthcare
- bone marrow
- ejection fraction
- randomized controlled trial
- mental health
- mesenchymal stem cells
- clinical trial
- prognostic factors
- palliative care
- intensive care unit
- high dose
- depressive symptoms
- patient reported outcomes
- spinal cord
- gene expression
- health insurance
- respiratory failure
- robot assisted
- study protocol
- placebo controlled
- phase ii
- middle aged
- adverse drug
- sleep apnea